Showing results (331-340 of 11,530) with videos related to
Sort By:
Pageof 1,153
British Journal of Clinical Pharmacology|June 26, 1999
Pharmacokinetic and pharmacodynamic characterization of OROS and immediate-release amitriptylineS K Gupta, J C Shah, S S HwangBritish Journal of Clinical Pharmacology|April 24, 1999
Risk of ventricular arrhythmias associated with nonsedating antihistamine drugsF J de Abajo, L A RodríguezBritish Journal of Clinical Pharmacology|April 24, 1999
Cytochrome P450 isoform selectivity in human hepatic theobromine metabolismS Gates, J O MinersBritish Journal of Clinical Pharmacology|September 30, 2000
Population pharmacokinetics of doxorubicin, etoposide and ifosfamide in small cell lung cancer patients: results of a multicentre studyG Freyer, B Tranchand, B Ligneau, et al.British Journal of Clinical Pharmacology|September 30, 2000
Pharmacodynamic and pharmacokinetic profile of S 17092, a new orally active prolyl endopeptidase inhibitor, in elderly healthy volunteers. A phase I studyP Morain, J L Robin, G De Nanteuil, et al.British Journal of Clinical Pharmacology|September 30, 2000
The rates of common adverse events reported during treatment with proton pump inhibitors used in general practice in England: cohort studiesR M Martin, N R Dunn, S Freemantle, et al.British Journal of Clinical Pharmacology|November 9, 2000
Steady-state pharmacokinetics of (R)- and (S)-methadone in methadone maintenance patientsD J Foster, A A Somogyi, K R Dyer, et al.British Journal of Clinical Pharmacology|November 9, 2000
Drug use of children in the community assessed through pharmacy dispensing dataE Schirm, P van den Berg, H Gebben, et al.British Journal of Clinical Pharmacology|January 3, 2001
The xenobiotic inhibitor profile of cytochrome P4502C8C E Ong, S Coulter, D J Birkett, et al.British Journal of Clinical Pharmacology|February 13, 2001
Pharmacodynamic models for the cardiovascular effects of moxonidine in patients with congestive heart failureL Brynne, J L McNay, H G Schaefer, et al.Pageof 1,153